GT Biopharma's TriKE™ Interim Clinical Trial Results Presented At Innate Killer Summit 2021

Retrieved on: 2021-03-29 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

GT Biopharma's TriKE™ Interim Clinical Trial Results Presented At Innate Killer Summit 2021. View article details on hiswai:

Excerpt

BEVERLY HILLS, Calif., March 29, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused ...

Article found on: www.prnewswire.com